EUVIMED · CrossrefJournal
American Journal of Cardiovascular Drugs
ISSN 1175-3277 · Springer Science and Business Media LLC
Latest articles
Endothelin Receptor Antagonists in CKD-Associated Resistant Hypertension: Trial Lessons, Safety Boundaries, and Conditions for Future Clinical Testing
Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
Effect of Intravenous Nicotinamide Adenine Dinucleotide on Left Ventricular Function After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial
Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies
Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration
Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly
Beta-Blockers After Myocardial Infarction Without Reduced Ejection Fraction: A Meta-Analysis of Kaplan–Meier Reconstructed Individual Patient Data
Iron Deficiency as a Modifiable Risk Factor in Heart Failure: Evidence and Recommendations
BCAA Metabolic Dyshomeostasis in Cardiovascular Disease: Pathogenic Mechanisms and Intervention
Impact of Prestroke Antiplatelet Therapy on the Efficacy of Intravenous Tirofiban at Preventing Early Neurological Deterioration: A Prespecified Subgroup Analysis of the TREND Trial
Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
Association of Glucagon-Like Peptide-1 Receptor Agonist with Incident Atrial Fibrillation
Emerging Role of Weight-Loss Medications in the Management of Heart Failure: Current Evidence and Future Perspectives
Meta-analysis of the Effect of Semaglutide on Blood Pressure in Obese Populations
The Effect of PCSK9 Monoclonal Antibodies on Platelet Reactivity and Cardiovascular Events in Patients Receiving Primary Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis
Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future
Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat
Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis
Vitamin D–Parathyroid Hormone–Fibroblast Growth Factor 23 Axis and Cardiac Remodeling
Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-analysis of 16 Randomized Controlled Trials
Flurpiridaz F 18: First Approval
A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension
Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies
EUVIMED